BSESattva Sukun Lifecare Ltd· RetailingHighNeutral
Announced Thu, 19 Feb, 2026 · 19:36 IST

Financial Result 31/12/2026

Pat NegativeRevenue DeclineExceptional ItemEbitda Margin CompressionResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.1%Reaction day
₹0.74
prior close
₹0.74
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-3.9% vs market
Retailing peers, median of 52sector · industry level-0.7%-3.3% vs sector

On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250 and 3.3 pts less than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+1.4
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.1-0.2-3.9-0.7-3.3
Next day
-1.4-0.0-1.3-1.2-0.2
2d
+0.0-1.3+1.3-3.6+3.6
3d
-1.4-1.1-0.2-3.6+2.3
4d
+8.1-0.8+9.0-3.6+11.7
5d
-4.1-1.9-2.1-4.0-0.1
1w
+2.7-6.6+9.3-7.9+10.6
15d
+0.0-9.7+9.7-11.5+11.5
1m
-2.7-8.2+5.5-10.9+8.2
2m
-5.4+3.1-8.5-1.1-4.3
3m
+1.4+5.9-4.5-2.5+3.9
UpDownMarket · Nifty Microcap 250Sector · Retailing peers, median of 52Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company reported weak standalone numbers for Q3 FY26, with revenue from operations falling sharply to Rs 72.75 lakhs from Rs 195.98 lakhs in the previous quarter and Rs 195.54 lakhs in Q3 FY25. The company slipped into a loss of Rs 70.66 lakhs in Q3 against a profit of Rs 60.40 lakhs in Q2, driven by an exceptional item of Rs 71.56 lakhs and a sharp jump in other expenses to Rs 93.29 lakhs (from Rs 12.08 lakhs a year ago). Standalone EPS turned negative at Rs (0.02). On a consolidated basis, nine-month revenue grew strongly to Rs 2,374.61 lakhs from Rs 421.14 lakhs, but Q3 still posted a Rs 69.49 lakh loss. The statutory auditor (SSRV & Associates) issued an unqualified limited review report.

Likely market impact

The sharp sequential revenue drop and a return to losses in Q3 are negative signals for shareholders, especially given the exceptional charge and ballooning other expenses. However, strong consolidated nine-month revenue growth and no deviation in use of rights issue funds (Rs 19.16 crore raised, Rs 18.08 crore utilised) provide some reassurance about the group's expansion.